| COOPERATION |
ORCHID BIOCOMPUTER ANNOUNCES COLLABORATION WITH BECKMAN COULTER -- Collaboration to Deliver High-Throughput SNP Genotyping Technology to Researchers Worldwide -- PRINCETON, N.J., Mar. 22, 1999 - Orchid Biocomputer, Inc. today announced that it has entered into a collaboration with Beckman Coulter, Inc. (NYSE: BEC) to develop a new high-throughput technology for conducting massive single nucleotide polymorphism (SNP) genotyping. The new automated assay platform being developed under the collaboration will become the core of Orchid's new SNPstream™ system, creating the most cost-effective means of SNP genotyping available to the industry. SNPstream is expected to genotype up to 30,000 SNPs per day, and is expected to be launched by Orchid in the third quarter of 1999. "We are very pleased to collaborate with Beckman Coulter as an acknowledged leader in automation systems and as one of our platform providers in the commercialization and licensing of our proprietary products," said Dale Pfost, Ph.D., president and chief executive officer of Orchid. Under the agreement, Beckman's SAGIAN™* Core System will be the platform for Orchid's SNPstream. Orchid will combine the automation technology with software and biochemistry to create a system for Orchid's final customers. SNPstream will enable researchers to rapidly analyze SNPs and their role in disease and drug efficacy. This research helps scientists to understand the role of genetic variation in disease and drug response, a field now being referred to as pharmacogenetics or pharmacogenomics. The system will initially be introduced to select research settings, including the Institute for Quantitative Systems Biology directed by Professor Leroy Hood at the University of Washington. "This collaboration offers both companies an exciting opportunity to advance genetic research by combining Orchid's pharmacogenetics expertise with our laboratory automation technology. Together we hope to give researchers the means to achieve new levels of productivity in their laboratory," said Jack Finney, vice president of bioresearch at Beckman Coulter. |
| UPDATE | 22.03.1999 |
| ALLIANCE |
- Beckman Coulter - Orchid BioComputer Inc |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |